Don't invest unless you're prepared to lose all the money you invest. This is a high-risk investment and you are unlikely to be protected if something goes wrong. Take 2 mins to learn more.
Three exciting new additions to the Access EIS portfolio for February 2025
Syndicate Room
13 March 2025•5 min read
In February 2025 we added three new startups to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our angel page. You can read about our new portfolio companies below.
If you're interested in making an investment and building your own portfolio of promising startups, you can read more about how to get started, or if you'd prefer to speak to our team about the benefits, angel co-investors, tax reliefs and potential for returns, you can use this link to schedule a call.
Anya
Winner of the National AI Awards for Healthcare in 2024, Anya is a digital health solution that combines pioneering AI technology with the expertise of human healthcare specialists to offer personalised 24/7 support for women's health from fertility through pregnancy to parenthood and menopause.
“Women’s healthcare has been underserved for far too long, and we’re on a mission to change that. At Anya, we combine cutting-edge AI with healthcare specialist support to provide women with the support they need to access the health information they need, whenever they need it in a way that suits them. With the backing of Lifted Ventures and other strategic partners, we’re excited to accelerate our global expansion and continue making a big difference in women’s lives. – Dr. Chen Mao Davies, Founder and CEO of Anya.
Anya works with healthcare providers, employers, local authorities and individuals to enhance the provision of support across the full spectrum of women's health needs. Its service includes a 24/7 virtual AI companion for immediate healthcare information; video consultations with specialists; personal tracking of symptoms and cycles; interactive 3D breastfeeding animations to support parents; and personalised content and self-care plans.
The company's leadership team includes Dan Cobley, a former MD at Google UK; angel investor Viktoria Tchoudakov, also a former Google employee and former head of Growth at personalised nutrition company Zoe, currently COO at EdTech Tiney; and Andrea Sinclair, UKBAA's Angel Investor of the Year in 2022.
Other investors in this round included Lifted Ventures.
Our angel partner in the round has an IRR of 31% and their previous investments include Plentific, Hybrid Air Vehicles & The Plum Guide.
Good & Proper Tea is on a mission to show the world how good tea can be. It's a speciality tea supplier based in London and offers a wide variety of premium quality, award-winning loose leaf teas, tea bags and tea accessories.
In addition to retail, the company offers a wholesale service for hospitality businesses who are looking to elevate their tea services.
What sets Good & Proper Tea apart from other suppliers? "“We have multiple USPs." Josh Mordecai revealed in an interview with [*Unleashed*](https://www.unleashedsoftware.com/blog/deep-dive-good-and-proper-tea/). "First is the quality of our tea. We go to great lengths to source really good teas, and we've been building up relationships with suppliers over the 12 years we've been in business. We do a lot of tasting to ensure that our products stand out and that we are sourcing the best possible tea we can for the price point that we're trying to hit."
Good & Proper Tea appointed the former head of Sainsbury's Future Brands, Tom Forsyth as Managing Director in October 2024.
Our angel partner in the round has a IRR of 141% and their previous investments include Xlinks, Freetrade & HireHand.
Snoring is a problem that affects 2.6 billion people worldwide, and the global anti-snoring device market is worth $3.1bn.
Zeus Sleep has developed anti-snoring technology that uses mild electric stimulation of the hyoglossus muscle to open the user's airways while asleep and prevent snoring. Unlike many anti-snoring devices, it is not worn in the mouth, and electricity is administered through an adhesive worn on the skin, avoiding the need for lengthy assessments, dental appointments, and expensive custom-made devices.
Our angel partner in the round has a IRR of 33% and their previous investments include Unmind, Percent and Itza Media.
Read our fund brochure for everything you need to know about the Access EIS Fund, which includes a full explanation of our innovative co-investment model to our fees, and instructions on how to invest. Register to download the brochure.
Investing in early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution, and it should be done only as part of a diversified portfolio. Tax relief depends on an individual’s circumstances and may change in the future. In addition, the availability of tax relief depends on the company invested in maintaining its qualifying status. Past performance is not a reliable indicator of future performance. You should not rely on any past performance as a guarantee of future investment performance.
This page has been approved as a financial promotion by Syndicate Room Ltd, which is authorised and regulated by the Financial Conduct Authority (No. 613021).
We use cookies to improve our service. By continuing to use this site you are agreeing to their use. Find out more.
Syndicate Room Ltd is registered in England and Wales. Number 07697935. Registered office: Wellington House, East Road, Cambridge, Cambridgeshire, CB1 1BH, United Kingdom
Please provide your email and/or phone number and we'll get back to you as soon as possible.
